SCHEMBL26075167

SCHEMBL26075167

CCOc1cccc(-c2cc(F)c(-c3cc(C)c4cc(F)ccc4n3)c(P)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 10/20 0.43
▸ NR3C1 P04150 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ BRD2 P25440 1/20 0.39
▸ CREBBP Q92793 1/20 0.39
▸ HPGD P15428 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075162 0.89 KDM4E (0.38) DHODHHPGDMAPTTP53SMN1; SMN2
SCHEMBL26075144 0.86 MAP4K4 (0.43) DHODHNR3C1MAP4K4BRD4BRD2
SCHEMBL26075140 0.83 MEN1 (0.41) DHODHNR3C1MAP4K4BRD4BRD2
SCHEMBL26075846 0.83 PTGS2 (0.40) DHODHNR3C1MAP4K4BRD4BRD2
SCHEMBL26075134 0.81 PTGS2 (0.47) DHODHNR3C1MAP4K4HPGDMAPT
SCHEMBL23590320 0.80 DHODH (0.55) DHODHHPGDTP53SMN1; SMN2MEN1
SCHEMBL26075147 0.78 DHODH (0.45) DHODHHPGDMAPTSMN1; SMN2MEN1
SCHEMBL26075150 0.78 MEN1 (0.46) DHODHNR3C1MAP4K4HPGDMAPT
SCHEMBL26075142 0.77 PDE10A (0.39) DHODHHPGDMAPTTP53SMN1; SMN2
SCHEMBL26075172 0.76 MEN1 (0.44) DHODHNR3C1MAP4K4HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885NR3C1 4803/4885MAP4K4 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback